biotech
Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on November 6, 2006
Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds
e-Therapeutics, a spin off biotech company from Newcastle University has partnered with Brazilian company Grupo TCI to establish a joint research facility close to the Amazonian and Atlantic rain forests. The collaboration aims to screen for lead compounds from the plants found in these rain forests. e-Therapeutics is also collaborating with CURA, a pharmaceutical consortium backed by the Brazilian Government.
Professor Young, who is now Pro-Vice-Chancellor at Newcastle University, said: 'This is a fantastic opportunity to investigate Brazil's colossal biodiversity with our cutting edge technology. There is enormous potential for drug discovery in the rain forests, where there are millions of plant species, many of which produce bioactive chemicals.'

More details from Newcastle University's press release.


Permalink: Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds
Tags: drug+discovery  medicines  rain+forest  biodiversity    biotech  lead+compounds  american+forests 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/41728
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds:

  • Currently 8.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.67 out of 3 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!